Search Results - Max McLaughlin-Callan
- Showing 1 - 1 results of 1
-
1
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial by Peter Schmid, Jacinta Abraham, Stephen Chan, Duncan Wheatley, Adrian Murray Brunt, Gia Nemsadze, Richard D. Baird, Winnie Yeo, Peter Hall, Timothy Perren, Robert C. Stein, László Mangel, Jean-Marc Ferrero, Melissa Phillips, John Conibear, Javier Cortés, Andrew Foxley, Elza C. de Bruin, Robert McEwen, Daniel Stetson, Brian Dougherty, Shah‐Jalal Sarker, Aaron Prendergast, Max McLaughlin-Callan, Matthew Burgess, Cheryl Lawrence, Hayley Cartwright, Kelly Mousa, Nicholas C. Turner
Published 2019Artigo
Search Tools:
Related Subjects
Alternative medicine
Apoptosis
Biochemistry
Breast cancer
Cancer
Chemistry
Chemotherapy
Clinical endpoint
Clinical trial
Confidence interval
Gastroenterology
Hazard ratio
Internal medicine
Medicine
Metastatic breast cancer
Oncology
PI3K/AKT/mTOR pathway
PTEN
Paclitaxel
Pathology
Placebo
Triple-negative breast cancer